Literature DB >> 8561111

Clinical analysis of choledochoduodenal fistula with cholelithiasis in Taiwan: assessment by endoscopic retrograde cholangiopancreatography.

B S Sheu1, J S Shin, X Z Lin, C Y Lin, C Y Chen, T T Chang, C Y Chen, P N Cheng.   

Abstract

OBJECTIVES: Choledochoduodenal fistula (CDF) is occasionally found during endoscopic retrograde cholangiopancreatography (ERCP). Cholelithiasis is suspected to be the leading cause in some endemic areas. We focus on this cause of CDF to determine which clinical characteristics are relevant to formation of fistulas and to learn whether CDF of various types would imply different clinical significance.
METHODS: In 1882 ERCP studies from 1988 to 1993, we found 27 CDF with cholelithiasis in 1066 patients. Their clinical backgrounds and ERCP findings were compared with those of 492 patients who had cholelithiasis but no CDF.
RESULTS: The prevalence of CDF was 2.53%. A longer past history of biliary stones, recurrent biliary tract infection (BTI), and the presence of common bile duct stones (CBS) were factors relevant to the formation of fistula. In the case of 24 distal fistulas, including seven of type I and 17 of type II, there was concurrent distal CBS. Three cardinal features of fistula of the distal type were: 1) the length of CDF was less than 1.5 cm, 2) its orifice was just around or on the papillary fold, and 3) all cases of distal type II had prominent pneumobilia, less jaundice, and larger CBS than type I. Aggressive endoscopic or surgical treatment of distal type CDF decreased the recurrence of BTI, as indicated by surveillance for 1 yr. Three fistulas of the proximal type were longer and drained into the duodenum far from the papilla. All of these cases deserved early surgical intervention.
CONCLUSIONS: CDF really serves as a chronic sequel of cholelithiasis. Different clinical features of CDF of various types help one to establish diagnosis and treatment. To avoid recurrence of BTI, aggressive therapy to correct CDF is mandatory.

Entities:  

Mesh:

Year:  1996        PMID: 8561111

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

1.  Importance of Spontaneous Choledochoduodenal Fistulas Detected During ERCP Procedure.

Authors:  Murat Akaydin; Okan Demiray; Ekrem Ferlengez; Fazilet Erozgen; Yeliz E Ersoy; Muzaffer Er
Journal:  Indian J Surg       Date:  2016-12-24       Impact factor: 0.656

2.  Comparison of endoscopic papillary balloon dilatation with conventional endoscopic sphincterotomy for peripapillary choledochoduodenal fistula with bile duct stones.

Authors:  Dong Shao; Jian Ping Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15

3.  Spontaneous Pneumobilia: Not So Benign.

Authors:  Abdul Ahad E Sheikh; Khalid H Ahmed; Sreekant Avula; Niraj J Shah; Mark M Aloysius
Journal:  Cureus       Date:  2021-04-14

4.  Stone-Induced Purulent Choledocoduodenal Fistula Presenting with Ascending Cholangitis.

Authors:  Christienne Shams; Michael Cannon; Jared Bortman; Seifeldin Hakim
Journal:  ACG Case Rep J       Date:  2018-08-29

5.  Choledochoduodenal fistula presenting with pneumobilia in a patient with gallbladder cancer: a case report.

Authors:  Elham Dadzan; Hossein Akhondi
Journal:  J Med Case Rep       Date:  2012-02-14

6.  New technique of endoscopic sphincterotomy with iso-tome® to incise the distal papillary roof in patients with choledocholiths and choledochoduodenal fistula.

Authors:  Young Sin Cho; Sang Heum Park; Baek Gyu Jun; Tae Hoon Lee; Hyun Jong Choi; Sang Woo Cha; Jong Ho Moon; Young Deok Cho; Sun Joo Kim
Journal:  Gut Liver       Date:  2015-03       Impact factor: 4.519

7.  Choledochoduodenal fistula: An unusual cause of recurrent cholangitis in children.

Authors:  Levent Duman; Cagri Savas; Aykut Recep Aktas; Mustafa Akcam
Journal:  J Indian Assoc Pediatr Surg       Date:  2014-07

8.  No Stone Left Unturned: Using Choledocholithiasis to Open a Papillary Stenosis via a Choledochodudenal Fistula.

Authors:  Sara West; M Joshua Shellenberger
Journal:  ACG Case Rep J       Date:  2016-01-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.